Search

Bryon W Petschow

from Lafayette, IN
Age ~70
Get Report
Also known as:
Bryan W Petschow, Byron W Petschow, Bryon W Petchow
Phone and address:
5140 S 1075 E, Lafayette, IN 47905
(919) 710-7254
Related to:
Sabrina J Wemlinger, 50David Lee, 68Erin P Ridings, 46Melinda M Ridings, 49Margaret RidingsTeresa Petschow, 36
Connected to:
Ashley Petschow, 42Kevin Petschl, 36Matthew T Petschl, 31Thomas J Petschl, 57Danise L Petsel, 60Gerald M Petsinger, 81Thomas C Petsinger, 65Elizabeth Petsios, 35Constance D Petska, 76Derek T Petska, 35

Bryon Petschow Phones & Addresses

  • 5140 S 1075 E, Lafayette, IN 47905 (919) 710-7254
  • Westfield, IN
  • 125 Kensington Dr, Youngsville, NC 27596 (919) 562-0485
  • 11 Hickory Hill Dr, Ewing, NJ 08618 (609) 771-0010 (609) 323-7414
  • Lawrenceville, NJ
  • 10622 Gettysburg Ct, Newburgh, IN 47630 (812) 853-7809
  • 10799 English Ct, Newburgh, IN 47630 (812) 853-2319
  • Evansville, IN
  • Franklin, NC
  • 125 Kensington Dr, Youngsville, NC 27596

Work

Company: Focus medical communications Jun 2010 to Jan 2013 Position: Senior vice president

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Michigan State University 2009 to 2011

Skills

R&D • Clinical Development • Science • Medical Education Process • Licensing/Contracts • Intellectual Property • Pharmacovigilance Agreements • Strategic Planning • Pharmaceuticals • Pharmaceutical Industry • Medical Writing • Management • Life Sciences • Clinical Research • Diabetes • Oncology

Interests

Social Services

Emails

l***[email protected]

Industries

Pharmaceuticals

Resumes

Resumes

Bryon Petschow Photo 1

Principal And Managing Director

View page
Location:
5140 South St east, Lafayette, IN 47905
Industry:
Pharmaceuticals
Work:
Focus Medical Communications Jun 2010 - Jan 2013
Senior Vice President
Transcend Biomedical Communications Jun 2010 - Jan 2013
Principal and Managing Director
Bristol-Myers Squibb Sep 2007 - Jun 2010
Director, Virology Independent Medical Education
Bristol-Myers Squibb 2006 - 2007
Director, External Affairs, Global Pharmacovigilance and Epidemiology
Mead Johnson Nutrition 1998 - 2006
Associate Director, Global Licensing and Regulatory Science
Education:
Michigan State University 2009 - 2011
Doctorates, Doctor of Philosophy Michigan State University 1978 - 1983
Doctorates, Doctor of Philosophy, Microbiology, Virology University of Wisconsin - La Crosse 1972 - 1976
Bachelors, Bachelor of Science, Biology, Chemistry Washington Park High School, Racine, Wi
Skills:
R&D
Clinical Development
Science
Medical Education Process
Licensing/Contracts
Intellectual Property
Pharmacovigilance Agreements
Strategic Planning
Pharmaceuticals
Pharmaceutical Industry
Medical Writing
Management
Life Sciences
Clinical Research
Diabetes
Oncology
Interests:
Social Services

Publications

Us Patents

Method For Simulating The Functional Attributes Of Human Milk Oligosaccharides In Formula-Fed Infants

View page
US Patent:
7572474, Aug 11, 2009
Filed:
Jun 30, 2005
Appl. No.:
11/172123
Inventors:
Bryon W. Petschow - Newburgh IN, US
Robert J. McMahon - Evansville IN, US
Glen R. Gibson - Reading, GB
Robert A. Rastall - Reading, GB
Renia Gemmell - Iffley, GB
Maria Saarela - Espoo, FI
Anna-Marja Aura - Espoo, FI
Assignee:
Mead Johnson Nutrition Company - Evansville IL
International Classification:
A23L 2/00
A61K 47/00
US Classification:
426590, 426801, 424439
Abstract:
The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Method For Simulating The Functional Attributes Of Human Milk Oligosaccharides In Formula-Fed Infants

View page
US Patent:
8277863, Oct 2, 2012
Filed:
Jul 2, 2009
Appl. No.:
12/497091
Inventors:
Bryon W. Petschow - Newburgh IN, US
Robert J. McMahon - Evansville IN, US
Glenn R. Gibson - Reading, GB
Robert A. Rastall - Reading, GB
Renia Gemmell - Lffley, GB
Maria Saarela - Espoo, FI
Anna-Marja Aura - Espoo, FI
Assignee:
Mead Johnson Nutrition Company - Evansville IN
International Classification:
A23L 2/00
US Classification:
426590, 426801
Abstract:
The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Nutritional Composition Having Prebiotic

View page
US Patent:
8557320, Oct 15, 2013
Filed:
Sep 4, 2012
Appl. No.:
13/602592
Inventors:
Bryon W. Petschow - Newburgh IN, US
Robert J. McMahon - Evansville IN, US
Glenn R. Gibson - Reading, GB
Robert A. Rastall - Reading, GB
Renia Gemmell - Iffley, GB
Maria Saarela - Espoo, FI
Anna-Marja Aura - Espoo, FI
Assignee:
Mead Johnson Nutrition Company - Glenview IL
International Classification:
A23L 2/00
US Classification:
426590, 426801
Abstract:
The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Composition And Method For Viral Inhibition

View page
US Patent:
20040191295, Sep 30, 2004
Filed:
Mar 28, 2003
Appl. No.:
10/401390
Inventors:
Mary Locniskar - Lawrence KS, US
Bryon Petschow - Newburgh IN, US
Robert Burns - Evansville IN, US
Virginia Sickles - Evansville IN, US
James Hansen - Evansville IN, US
Steven Rumsey - Evansville IN, US
International Classification:
A61K031/7012
A61K047/00
US Classification:
424/439000, 514/053000
Abstract:
A method for inhibiting Rotavirus infection by administering effective amount of lactulose is provided. Lactulose can be administered alone, in combination with other nutrient supplements such as vitamins, or as part of a nutritional product such as infant formula.

Composition And Method For Viral Inhibition

View page
US Patent:
20050014717, Jan 20, 2005
Filed:
Jul 8, 2004
Appl. No.:
10/886760
Inventors:
Mary Locniskar - Lawrence KS, US
Bryon Petschow - Newburgh IN, US
Robert Burns - Evansville IN, US
Virginia Sickles - Evansville IN, US
James Hansen - Evansville IN, US
Steven Rumsey - Evansville IN, US
International Classification:
A61K031/7012
A61K047/00
US Classification:
514053000, 424439000
Abstract:
A method for inhibiting infection by administering effective amount of lactulose is provided. Lactulose can be administered alone, in combination with other nutrient supplements such as vitamins, or as part of a nutritional product such as infant formula.

Composition And Method For Viral Inhibition

View page
US Patent:
20050276838, Dec 15, 2005
Filed:
May 26, 2005
Appl. No.:
11/138585
Inventors:
Mary Locniskar - Lawrence KS, US
Bryon Petschow - Newburgh IN, US
Robert Burns - Evansville IN, US
Virginia Sickles - Freeland WA, US
James Hansen - Evansville IN, US
International Classification:
A61K031/7012
A61K039/15
US Classification:
424439000, 514053000
Abstract:
A method for inhibiting Rotavirus infection by administering effective amount of lactulose is provided. Lactulose can be administered alone, in combination with other nutrient supplements such as vitamins, or as part of a nutritional product such as infant formula.

Method For Extending The Shelf-Life Of Powdered Nutritional Formulations Which Contain Viable Probiotics

View page
US Patent:
20080095752, Apr 24, 2008
Filed:
Oct 20, 2006
Appl. No.:
11/584302
Inventors:
Bryon W. Petschow - Ewing NJ, US
Adrie Baars - Hengelo, NL
Yung H. Lee - Evansville IN, US
Luis Jose Montelongo - Lawrence KS, US
Nagendra Rangavajla - Newburgh IN, US
International Classification:
A61K 35/74
A61K 31/715
US Classification:
424 9345, 514 61
Abstract:
The invention involves a method for extending the shelf life of a powdered nutritional formulation that contains LGG by reducing and maintaining a threshold water activity or moisture content in the powdered LGG-containing formulation.

Method For Inhibiting The Growth Of Bacteria

View page
US Patent:
20090298937, Dec 3, 2009
Filed:
Apr 24, 2009
Appl. No.:
12/429571
Inventors:
Bryon W. Petschow - Ewing NJ, US
Assignee:
MEAD JOHNSON NUTRITION COMPANY - Evansville IN
International Classification:
A61K 31/23
A61P 31/04
US Classification:
514547
Abstract:
The present invention is directed to a method for inhibiting the growth of pathogenic bacteria in an infant formula comprising supplementing the infant formula with at least one diglyceride antimicrobial agent.
Control profile
Bryon W Petschow from Lafayette, IN, age ~70 Get Report